We previously observed that a subset of HNSCC tumors exhibit very low Trop2 expression, but most HNSCC tumors show heterogeneous expression at the cellular level when assessed by immunohistochemistry42. The gene discussed is TACSTD2; the disease is head and neck squamous cell carcinoma.